AKT1 and lung carcinoma: In addition, blocking PI3K/AKT, as the downstream pathway activated by IL6, can inhibit the differentiation of osteoclasts induced by lung cancer cells or interleukins [51], which highlights the important role of IL6 in bone homeostasis.